Search results for "COPD"
showing 10 items of 483 documents
Late Breaking Abstract - Dose-ranging study of mepolizumab in eosinophilic COPD
2018
Background: Patients with eosinophilic COPD & frequent exacerbations may benefit from mepolizumab (MEP) treatment. Objective: Assess efficacy & safety of 2 MEP doses vs placebo (PBO) in COPD with blood eosinophils ≥150 cells/µL [screening] or ≥300 cells/µL [prior yr], history of ≥2 moderate/≥1 severe exacerbations & ICS+≥2 bronchodilator maintenance therapies (ICS+MT). Methods: Phase III, randomised, PBO-controlled, double-blind, parallel-group trial (METREO); patients received SC MEP 100mg, MEP 300mg or PBO plus ICS+MT, every 4 wks for 52 wks. Primary endpoint: rate/yr of moderate (systemic corticosteroids/antibiotics)/severe(hospitalisation or death) exacerbations. Secondary endpoints inc…
Comparación del Vitalograph COPD-6® y del Air Smart Spirometer® con la espirometría estándar en el despistaje y el diagnóstico de los pacientes con E…
2020
La enfermedad pulmonar obstructiva crónica (EPOC) está infradiagnosticada aunque mejora su evo- lución y pronóstico si se trata precozmente y su principal tratamiento es la abstinencia tabáquica. El objetivo principal de este estudio es comparar los espirómetros de campo COPD-6 ® (Vitalograph) y Air Smart Spirometer® con la espirometría estándar en el diagnóstico de la obstrucción bronquial. Los objetivos secundarios son: determinar cuál de los dos espirómetros estudiados es más eficaz y/o eficiente; detectar los falsos positivos que generan y valorar su aportación a la deshabituación tabá- quica. Participaron 185 pacientes del Centro de Salud Fuensanta con o sin síntomas o signos sugestivo…
The difference in risk of chronic pulmonary disease morbidity and mortality between elite athletes and ordinary men in Finland
2020
Introduction: The impact of a history of competitive sports on later smoking behavior and occurrence of chronic pulmonary diseases is poorly known. We investigated how a history of elite level sports predicted later pulmonary disease morbidity and mortality. Methods: Chronic pulmonary disease incidence were assessed from national hospital and cause-of-death registers from 1970 to 2015 among Finnish male former elite athletes (n=2078) and matched controls (n=1453) alive in 1970 (mean age 45.0 years). Hazard ratios (HRs) were calculated by Cox proportional hazards model. In 1985, cohort members reported on their smoking habits, engagement in physical activity/sports and physician-diagnosed ch…
Soporte telefónico al paciente con EPOC en tiempos de la COVID-19
2020
Resumen: La imposición del estado de alarma por el Gobierno Español como principal medida para evitar el contagio ha supuesto un cambio en la aproximación clínica al paciente crónico. Aunque las nuevas tecnologías de la comunicación nos ofrecen numerosas formas de establecer un contacto directo, pero en la distancia, las peculiaridades del paciente con EPOC hacen que con frecuencia esta atención sanitaria se vea reducida al teléfono. El reto de atender a los pacientes con EPOC por teléfono supone una complejidad añadida a la atención sanitaria. La entrevista se realizará sin la exploración del paciente, sin nuevas pruebas complementarias y sin poder verificar la técnica inhalatoria. Por tan…
Smoke exposure affects gelatinase A and B activity levels in two lung epithelial cell lines
2006
Breathing woodwinds : music therapy for asthma and COPD rehabilitation
2014
Filhan(2010) arvion mukaan hengityssairaudet koskettavat vuosittain miljoonaa suomalaista. Tutkimus tarjoaa vaihtoehdon potilaan omaa vastuuta korostavaan kuntoutukseen. Astmaryhmälle, kaksi lasta ja aikuinen, sekä keuhkoahtaumapotilaalle annettiin 12 viikkoa puhallinsoittimiin painottuvaa musiikkiterapiaa. Hengitysharjoituksia ja puhallinsoittimien soittoa käytettiin hengityselinten vahvistamiseksi musiikin tuodessa harjoitteluun motivaatiota. Voiko puhallinsoittimia painottava musiikkiterapia normaalihoitoon lisättynä vaikuttaa myönteisesti hengityssairauksista kärsivän elämänlaatuun? Kahdentoista viikon tuloksissa kvalitatiivinen materiaali antoi tuloksia. PEF lukemat pysyivät samoina, m…
Why, whether and how to use high-flow nasal therapy in acute exacerbations of chronic obstructive pulmonary disease
2021
Noninvasive ventilation (NIV) represents the standard of care for respiratory support of patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) developing acute hypercapnic respiratory failure (AHRF) [1]. NIV has been shown to reduce patient’s work of breathing and mortality and be feasibly implemented in various hospital location facilities at different timing, based on the severity of AHRF [2] and it is also widely used in clinical practice by physicians [3]. However, clinicians’ knowledge, experience and expertise in the management of NIV are crucial for its success in order to overcome common problems that may lower its effectiveness such as patients’ discomf…
The geriatric asthma: pitfalls and challenges
2016
Historically, asthma has been envisioned as a disease of younger ages. This has led to the assumption that respiratory symptoms suggestive of asthma occurring in older ages are to be attributed to conditions other than asthma, mainly COPD. Old observational reports and new epidemiological studies confirm that asthma is as frequent in older as it is in younger populations. Nevertheless, under-recognition, misdiagnosis and under-treatment are still relevant issues. The characterization of asthma in the aged suffers from the fact that there has been very little original research in this field. Indeed, geriatric asthma is often excluded from clinical trials because of age and comorbidities. The…
Validation of Murray sputum purulence scale in the Italian Registry of Bronchiectasis (IRIDE)
2018
Introduction: Murray sputum colour chart stratifies patients according to the presence of mucous (M), muco-purulent (MP) or purulent (P) sputum, and has not been validated in Bx yet. We aimed to validate this scale across a large Italian cohort of Bx patients. Methods: A secondary analysis of the IRIDE database was conducted including adults with Bx and daily sputum production enrolled across 13 Italian centres between 2014 and 2017. M vs. MP vs. P sputum producers were identified and clinical, functional and microbiological data were collected. Clinical outcomes during a two-year follow up period were evaluated in the Monza and Milan cohorts. A sensitivity analysis excluding COPD patients …